Corresponding to its mission to promote, support, develop and provide a forum for exchange of information about acne and rosacea, the AARS has developed Clinical Audiopearls as part of our educational initiative program. For this initiative, the AARS will conduct an interview with a member of the Society regarding a hot topic in acne and rosacea science or treatment. Stay in the know and choose from one of the topics highlighted below to hear the latest news!
Oral Contraceptive Use in the Treatment of Acne
In 2010, AARS President Dr. James Del Rosso interviewed Dr. Julie Harper about the use of oral contraceptives in the treatment of acne. Listen below to hear what was discussed!
The following references were used by Dr. Harper in this interview:
Stewart F, Harper C, Ellertson C, Grimes D, Sawaya G, Trussell J. Clinical breast and pelvic examination requirements for hormonal contraception. JAMA 2001;285(17):2232-2239.
Burkman R, Schlesselman J, Zieman M. Safety concerns and health benefits associated with oral contraception. Am J Obstet Gynecol 2004;190:S5-22.
Seeger, Loughlin J, Eng PM, Clifford CR, Cutone J, Walker AM. Risk of thromboembolism in women taking ethinyl estradiol/drospirenone and other oral contraceptives. Obstet Gynecol 2007;110(3):587-93.
Lidegaard O, Lokkegaard E, Svendsen AL, Agger C. Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ 2009;Aug 13;339:b2890. doi:10.1136/bmj.b2890.
Dinger JC, Heineman LA, Kuhl-Habich D. The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 woman-years of observation. Contraception 2007;75(5):344-354.
Updates in the Management of Rosacea
For this Clinical Audiopearl, conducted in 2010, Stacey Moore, Executive Director of the American Acne and Rosacea Society talked with AARS President Dr. James Del Rosso about current updates in the management of rosacea. Tune in to hear what was said!
Novelties in Acne Pathogenesis
This Clinical Audiopearl features an interview with AARS 2010 President-Elect, Dr. Diane Thiboutot. Listen below as she and current AARS president Dr. James Del Rosso discussed novelties in acne pathogenesis.
Childhood Acne
During 2010, upcoming AARS president Diane Thiboutot, MD, interviewed Andrea Zaenglein, MD, about the difficulties surrounding childhood acne.
The following references were used in Dr. Zaenglein's discussion about childhood acne:
Antoniou C, Dessinioti C, Stratigos AJ, Katsambas AD. Clinical and therapeutic approach to childhood acne: an update. Pediatr Dermatol. 2009 Jul-Aug;26(4):373-80.
Rosenfield RL. Clinical review: Identifying children at risk for polycystic ovary syndrome. J Clin Endocrinol Metab. 2007 Mar;92(3):787-96.
P. Acnes Decreased Sensitivity to Antibiotics
This Clinical Audiopearl is the first of a two-part series of talks in 2011 with Dr. Jim Leyden. Dr. Leyden discusses with Dr. James Del Rosso the history of P. Acnes as it relates to clinical studies and scientific knowledge, and talks about key points to consider in acne treatment today due to P. Acnes resistance to antibiotics.
The following references relate to Dr. Leyden's discussion of P. Acnes resistance to antibiotics:
Ross JI, Snelling AM, Eady EA, Cove JH, et al. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the USA, Japan and Australia. Br J Dermatol. 2001 Feb;144(2):339-46.
Ross JI, Snelling AM, Carnegie E, Coates P, et al. Antibiotic-resistant acne: lessons from Europe. Br J Dermatol. 2003 Mar;148(3):467-78.
Gollnick H, Cunliffe W, Berson Dreno B, et al; Global Alliance to Improve Outcomes in Acne. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003 Jul;49(1 Suppl):S1-37.
Del Rosso JQ, Kim G. Optimizing use of oral antibiotics in acne vulgaris. Dermatol Clin. 2009 Jan;27(1):33-42.
Del Rosso JQ, Leyden JJ, Thiboutot D, Webster GF. Antibiotic use in acne vulgaris and rosacea: clinical considerations and resistance issues of significance to dermatologists. Cutis. 2008 Aug;82(2 Suppl 2):5-12.
Leyden JJ, Del Rosso JQ, Webster GF. Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance. Cutis. 2007 Jun;79(6 Suppl):9-25.
Truncal Acne Vulgaris
In this second part to the two part 2011 Clincial Audiopearl series with Dr. Jim Leyden, AARS President Dr. James Del Rosso explores treatment options for acne on the chest and back and offers tips for the management of truncal acne.
The following references support the discussion of Dr. Leyden and Dr. Del Rosso regarding truncal acne:
Leyden JJ. Efficacy of benzoyl peroxide (5.3%) emollient foam and benzoyl peroxide (8%) wash in reducing Propionibacterium acnes on the back. J Drugs Dermatol. 2010 Jun;9(6):622-5.
Leyden JJ, Wortzman M, Baldwin EK. Antibiotic-resistant Propionibacterium acnes suppressed by a benzoyl peroxide cleanser 6%. Cutis. 2008 Dec;82(6):417-21.
Del Rosso JQ. Benzoyl peroxide cleansers for the treatment of acne vulgaris: a status report on available data. Cutis. 2008 Nov;82(5):336-42.
Del Rosso JQ. Truncal acne vulgaris: the relative roles of topical and systemic antibiotic therapy. J Drugs Dermatol. 2007 Feb;6(2):148-51.
